ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Strength training for health in adults: Terminology, principles, benefits, and risks

Strength training for health in adults: Terminology, principles, benefits, and risks
Literature review current through: Jan 2024.
This topic last updated: Nov 13, 2023.

INTRODUCTION — Physical inactivity is a major health problem worldwide and predisposes to a wide variety of chronic degenerative diseases, including cardio-cerebrovascular disease, metabolic disease, musculoskeletal disorders, and frailty. Physical exercise has well-documented beneficial effects on numerous health outcomes, including cardiovascular disease and all-cause mortality [1]. Strength training has attracted increasing attention in the biomedical literature as a powerful and beneficial form of exercise [2-4].

To properly prescribe and monitor strength training for their patients, clinicians need to understand the forms of strength training and their implementation, benefits and risks, contraindications, and necessary modifications for special populations.

This topic will discuss some of the general principles of strength training for adults, provide an overview of its many health benefits, and describe potential risks. Guidelines for implementing strength training programs in adults, some common misconceptions about strength training, and strength training in the pediatric population are reviewed separately. (See "Practical guidelines for implementing a strength training program for adults" and "Physical activity and strength training in children and adolescents: An overview".)

The benefits of exercise generally and for prevention or management of specific conditions are reviewed separately. (See "The benefits and risks of aerobic exercise" and "Exercise prescription and guidance for adults" and "Exercise and fitness in the prevention of atherosclerotic cardiovascular disease" and "Obesity in adults: Role of physical activity and exercise" and "Exercise in the treatment and prevention of hypertension" and "Exercise guidance in adults with diabetes mellitus".)

WHAT IS STRENGTH AND WHY IS IT IMPORTANT? — Muscular strength is defined as the ability to produce force against a resistance. Strength may be displayed dynamically, as in Olympic weightlifting or running, or statically, as in activities like gymnastics and yoga [5]. Dynamic and static force production can be applied discretely or repeatedly depending on the task. Weightlifting demands discrete, dynamic force production whereas running requires repeated, dynamic force production; however, force production is equally important to both activities [5]. Accordingly, the ability to generate muscular force has positive implications for virtually every other fitness attribute, including power, balance, agility, speed, endurance, and flexibility [6].

Power is the first derivative of strength with respect to time; it is the ability to produce force quickly. Endurance is the ability to produce force repeatedly over sustained intervals, usually in repetitive motor patterns (eg, running, bicycling, swimming). Full mobility requires not only joint integrity but also the ability to produce force over a full range of motion. Balance is the ability to maintain a stable position against the pull of gravity with minimal postural sway [7] and depends on both intact proprioception and the ability to produce muscular force. Muscular strength and muscle tissue also protect against injury [8,9], frailty [10-12], falls [13], and loss of independence. Fatigue, which is any reduction in force-generating capacity, reduces performance in all of these domains [14]. Therefore, the ability to produce muscular force (ie, strength) is a fundamental physical fitness attribute that influences all others.

STRENGTH TRAINING: DEFINITION AND KEY PRINCIPLES — Strength training is a rational, explicit program of carefully chosen exercises performed over an extended period and designed to increase the subject's ability to produce muscular force in useful movement patterns. This goal cannot be realized by sporadic, unplanned, random bouts of exercise but rather requires the careful and progressive manipulation of training variables over time [6,15-18].

The Stress-Recovery-Adaptation model provides a useful conceptual framework for the development of physical training programs [15,19]. In this model, a training stress is imposed, the trainee recovers from and adapts to the stress, and they subsequently demonstrate this adaptation as an increase in performance. Thus, the Stress-Recovery-Adaptation cycle corresponds to a training period, and the proper exploitation of this phenomenon forms the foundation of any rational strength training program.

Physicians, patients, and fitness professionals must understand the pivotal role of recovery in this paradigm. Elements of proper recovery include both training variables and lifestyle variables and promote not only productive strength acquisition but also general health. These recovery variables include:

Proper nutrition

Adequate sleep

Active rest (light, unstructured physical activity on non-training days)

Stress management [15-17]

Strength training relies on the principle of progressive overload, a steady increase in the applied training stress, which produces a corresponding increase in physiologic and performance adaptation. At the most basic or novice level of training, progressive overload can be achieved by simply increasing the load while holding other factors (eg, number of sets for a given exercise, number of repetitions in a given set) constant. (See "Practical guidelines for implementing a strength training program for adults".)

However, as the trainee gets stronger, this "linear" progression becomes less productive, and more complex programming strategies are needed, incorporating more sophisticated manipulation of volume (sets and repetitions), intensity (loading), training frequency, exercise selection, recovery, etc. These intermediate and advanced approaches are beyond the scope of this topic but are treated in detail in other resources [15-17,20].

In summary, strength training is most efficiently, productively, and safely implemented by using a systematic, programmed approach and relying on the appropriate imposition of training stress, progressive overload, adequate and carefully managed recovery, and demonstration and exploitation of adaptation to training stress.

WHAT ARE THE BENEFITS OF STRENGTH TRAINING?

General benefits — Strength training, as a form of physical exercise, confers the general benefits (and risks) of any form of regular, vigorous physical activity. These are explored at length separately, and a detailed examination is outside the scope of the present discussion. (See "The benefits and risks of aerobic exercise".)

To summarize, all forms of regular exercise confer manifold beneficial effects at multiple strata of biological organization, with improvements in health at the cellular, metabolic, cardiovascular, neurologic, and functional levels. At the cellular level, regular exercise promotes optimal energy utilization and improved resistance to oxidative stress [21-26]. All forms of vigorous exercise promote improved glucose disposal during the exercise bout itself because muscle glucose uptake during exercise is insulin independent [27,28]. Regular exercise increases insulin sensitivity [29-31] and is therefore an important treatment in the management and prevention of metabolic syndrome and type 2 diabetes [32-35]. (See "Prevention of type 2 diabetes mellitus", section on 'Exercise'.)

Resistance training improves body composition, leading to increases in lean body mass and decreases in fat, including visceral fat, an important risk factor for the development of metabolic syndrome, diabetes, and chronic systemic inflammation [36]. Exercise, including strength training, has well-established benefits to the cardiovascular system [37], including cardiac remodeling [38], improvements in blood pressure [39], and moderation of cardiac risk factors [40,41]. Finally, resistance training may confer functional benefits, with improvements in psychosocial health, depression, and sleep [42-45], although the data on functional outcomes are decidedly mixed and hampered by wide variations in experimental approach, methodologic quality, and outcome assessment [46]. (See "Obesity in adults: Role of physical activity and exercise" and "Exercise in the treatment and prevention of hypertension".)

Common study flaws and benefits in females and older adults — The results of several major trials have raised questions about the health benefits of strength training. However, fundamental flaws in programming and implementation raise doubts about these results. A notable example is the DO-HEALTH trial, which evaluated the effect of vitamin D supplementation, omega-3 fatty acid supplementation, and strength training on a range of clinical outcomes in older adults [47]. This study found a negligible impact of the chosen strength training intervention on blood pressure, rates of nonvertebral fractures, infection, physical performance, and cognition at three years. However, the study had several important limitations that are common in the broader medical literature about resistance exercise. The intervention did not feature progressive loading or adequate documentation of dosing, adherence, or progress. Most importantly, there was no demonstration that the intervention produced increases in strength. By definition, a strength training intervention that does not increase strength was not properly performed.

While there is broad heterogeneity among individual adaptive responses to physical training interventions, true nonresponsiveness does not appear to occur with sufficient dosing and duration [48-50]. Ample evidence challenges common assumptions about limited strength and hypertrophy responses in females and older adults. A systematic review of 24 studies of resistance training in females found medium-to-large effect sizes on strength and muscle hypertrophy outcomes, particularly with higher exercise dosing [51]. Similar findings have been reported in meta-analyses of controlled trials in individuals over 75 years of age [52].

When an investigation of an intervention (strength training) with a putative mechanism of action (increased strength and muscle hypertrophy) fails to demonstrate that the intervention was administered in a formulation and dose adequate to activate that underlying mechanism (strength training program did not increase strength), readers should question claims that the intervention is ineffective. Studies evaluating the impact of strength training protocols in older adult populations are abundant. However, few studies have used protocols that incorporate progressive loading, impose stress to the axial skeleton and hips, promote muscle growth, and actually increase strength.

Specific benefits — Strength training confers progressive improvements in several important fitness and health parameters not observed for other forms of exercise. Strength training obviously improves strength, the ability to produce muscular force [53]. It also improves power, the ability to express force quickly, which is closely tied to the fitness attributes of speed and agility. Strength training promotes muscle protein accretion and gains in muscle mass. When combined with appropriate nutrition, it is probably the single most powerful medicine against sarcopenia [54], endemic in older adult populations and a contributing factor to frailty and metabolic syndromes. The data on strength training and bone mineral density maintenance and improvement suggest a similar beneficial effect from strength training [55-58]. (See "Frailty", section on 'Exercise' and "Overview of the management of low bone mass and osteoporosis in postmenopausal women", section on 'Exercise'.)

Strength training, unlike most forms of endurance training [58], promotes significant increases in anaerobic capacity [59]. Strength training does not appear to produce significant improvements in maximum rate of oxygen consumption (VO2max) and other biomarkers of improved mitochondrial metabolism [60-63], although there are contrary reports [64]. Some reports indicate improvement in aerobic metabolism in older subjects [65-67], but these data are hampered by small sample sizes and methodologic issues. However, multiple studies have demonstrated improvements in endurance performance and work capacity, especially in untrained individuals [67-70]. The available evidence suggests a broad range of individual variation in the adaptive response to a given standardized training intervention, and the type and magnitude of benefit can vary significantly based on the specific features of program design [71,72].

We recommend the addition of a conditioning component to any strength training program. For very frail patients who cannot perform sustained aerobic activity, we find it prudent to complete a strength-focused novice phase of training in order to develop the minimal strength necessary for subsequent conditioning exercise. The available data indicate that strength training combined with cardiovascular conditioning (either classical aerobic conditioning or interval training) confers greater health benefits than either modality alone [40,73,74]. (See "Practical guidelines for implementing a strength training program for adults" and "Exercise for adults: Terminology, patient assessment, and medical clearance".)

Mortality benefit — A large and growing evidence base shows a strong correlation between physical strength and a reduction in all-cause mortality across the lifespan [75-81]. In a systematic review and meta-analysis of 16 studies involving several hundred thousand participants, strength training was inversely associated with the risk for cardiovascular disease (RR 0.83, 95% CI 0.73-0.93), cancer (RR 0.88, 95% CI 0.80-0.97), diabetes (RR 0.83, 95% CI 0.77-0.89), and all-cause mortality (RR 0.85, 95% CI 0.79-0.93) independent of aerobic exercise activities [77]. The review, which was limited to prospective studies of adults aged 18 years or older without severe health conditions at baseline and a minimum two-year follow-up, likely underestimates these benefits as not all studies involved robust training methods. (See 'Common study flaws and benefits in females and older adults' above.)

Notable individual studies include the following:

A prospective study of over 1.1 million Swedish male adolescents over 24 years of age found that greater muscular strength (assessed by handgrip and knee extension) was associated with a 25 to 30 percent reduction in premature mortality due to any cause or due to cardiovascular disease, independent of body mass index or blood pressure [78].

A prospective study of 555 adults aged 85 found that individuals in the lowest tertile of handgrip strength at the study's outset had a 35 percent increased risk of all-cause mortality at follow-up (average 9.5 years); those in the lowest tertile at age 89 had a 104 percent increased risk of mortality at follow-up, and those showing the greatest strength decline over four years had a 72 percent increased risk of mortality [79].

A prospective study involving 4449 older adults found that low muscle strength was independently associated with elevated risk of all-cause mortality, regardless of muscle mass, metabolic syndrome, sedentary time, or leisure-time physical activity [80].

WHAT MEDICAL CONDITIONS IMPROVE WITH STRENGTH TRAINING? — An exhaustive review of the impact of strength training is beyond the scope of this topic. Below, we highlight those areas with the largest public health impact and greatest amount of supporting data.

Endocrine-metabolic — Muscle is increasingly recognized as an important endocrine and metabolic tissue [82-85]. Strength training, which increases the mass, function, and health of muscle tissue, has profound effects on metabolic health and body composition.

Obesity — The authors routinely prescribe strength training for obese individuals who have no contraindication to this form of exercise. We typically prescribe concomitant caloric restriction to produce weight loss and advise patients to participate in interval conditioning or aerobic exercise for optimal improvements in health [16,40,73,74]. According to meta-analyses of relevant studies, resistance training without dietary restriction appears to be less effective for weight loss in obese patients [86,87]. However, dietary restriction combined with exercise appears to produce up to approximately 20 percent greater weight loss initially, with better maintenance of weight loss at one year, than dietary restriction alone. (See "Practical guidelines for implementing a strength training program for adults" and "Obesity in adults: Dietary therapy" and "Exercise for adults: Terminology, patient assessment, and medical clearance".)

Obese patients tend to be more resistant to muscle-specific anabolic stimuli (exercise and dietary protein) than nonobese controls, generating a lower muscle protein synthetic response to these stimuli [88-90]. This is thought to be due to the metabolic effects of chronic systemic inflammation, intramyocellular lipid accumulation, and alterations in gene expression. However, obese individuals can increase lean body mass without gaining bodyweight and, in some cases, even while losing weight. The addition of skeletal muscle tissue may also increase resting metabolic rate. This may explain in part how resistance training prevents further weight gain in obese individuals, and regaining of weight in successful dieters [91-95].

In addition to preserving or even increasing muscle mass while in a hypocaloric state, resistance training may be at least as effective as diet and/or aerobic training at reducing abdominal obesity through reductions in visceral and subcutaneous adipose tissues [96-98].

An elevated waist circumference of ≥40 inches (102 cm) for men and ≥35 inches (88 cm) for women is indicative of increased cardiometabolic risk. Resistance training produces a modest decrease in waist circumference even in the absence of weight loss, although the effect appears to be more pronounced when weight loss occurs [40,99]. In addition, regular participation in resistance training appears to prevent or attenuate the waist circumference increase seen with aging [100]. (See "Obesity in adults: Prevalence, screening, and evaluation", section on 'Waist circumference'.)

Decreased body fat percentage — Body fat percentage is the ratio of fat mass to total body mass, expressed as a percentage. If the total mass of body fat is decreased or fat-free mass is increased, the body fat percentage decreases. Strength training is an effective means for decreasing body fat percentage by increasing skeletal muscle mass (a component of fat-free mass), decreasing fat mass, or both [88,95,101-104].

Metabolic syndrome — Metabolic syndrome, a constellation of findings arising from a complex pathophysiology driven primarily by insulin resistance, has become a major health problem. The specific criteria used to define metabolic syndrome vary among major health organizations but include elevated serum glucose, dyslipidemia, hypertension, and increased waist circumference. (See "Metabolic syndrome (insulin resistance syndrome or syndrome X)".)

Resistance training not only addresses the clinical features of metabolic syndrome but also attacks the underlying state of insulin resistance, and the authors believe it is an essential part of any exercise prescription for its treatment or prevention. Meta-analyses of resistance training's effect on insulin resistance in those with diagnosed metabolic syndrome show improvement in both insulin sensitivity and diagnostic criteria [4,105,106]. As an example, one small randomized trial reported decreases in HbA1C, fasting insulin, fasting blood sugar, and HOMA-IR (homeostasis model assessment of insulin resistance) values after 16 weeks of strength training compared with controls managed with standard care alone [107]. A meta-analysis of 13 randomized controlled trials on the effect of resistance training on those with metabolic syndrome found an average 0.48 percent reduction in HbA1c (95% CI -0.76 to -0.21), a 2.33 kg reduction in fat mass (95% CI -4.71 to 0.04), and 6.19 mmHg reduction in systolic blood pressure (95% CI 1.00-11.38) [108].

Diabetes — The most recent exercise recommendations of the American Diabetes Association include both aerobic and resistance training and are in agreement with the guidelines for nondiabetic adults put forth by the American College of Sports Medicine (ACSM) and the United States Centers for Disease Control and Prevention (CDC) [109-111]. We concur and recommend strength training as an essential part of the exercise prescription for patients with diabetes [16]. (See "Exercise guidance in adults with diabetes mellitus".)

Strength training increases serum glucose uptake and oxidation, both during and following exercise, in populations with and without diabetes, including obese nondiabetics [112,113]. However, in patients with a history of impaired fasting glucose, type 1 or type 2 diabetes, or a history of hyper- or hypoglycemia, we agree with the recommendations put forth by the ACSM, which state that a pre-exercise blood glucose greater than 250 mg/dL (13.9 mmol/L) or the presence of ketosis should be considered a contraindication to vigorous exercise. Such patients should be referred to their physician. Glucose management for diabetics during exercise is reviewed in detail separately. (See "Exercise guidance in adults with diabetes mellitus", section on 'Glycemic management during exercise'.)

In the authors' suggested approach to strength training, exercise movements are generally performed at an intensity (expressed as percentage of one-repetition maximum [1RM]) of >70 percent for three to eight repetitions. In addition, the majority of exercises entail the movement of multiple joints involving multiple large muscle groups to produce the forces necessary to perform the movement under load. (See "Practical guidelines for implementing a strength training program for adults".)

This combination of volume (total repetitions), intensity, and muscle mass recruitment produces a large increase in metabolic activity. This includes both substrate-level phosphorylation by adenosine triphosphate (ATP) and the creatine cycle and robust glycogenolysis in the active muscle tissue. This intense metabolic demand increases the uptake of glucose from the circulation and its rapid conversion to energy [114]. Although patients with diabetes or metabolic syndrome have varying deficits in serum glucose uptake into cells due to insulin resistance, their rate of glucose uptake and oxidation during strength training is similar to lean controls due to the insulin-independence of glucose transport during exercise [115,116]. Strength training stimulates translocation of the glucose transporter GLUT4 to the sarcolemma of working skeletal muscle in an insulin-independent fashion, improving glucose uptake for subsequent energy production or storage as glycogen, even in the setting of insulin resistance [105,113,115-120].

Resistance training increases the basal rate at which glucose is stored in muscle by increasing skeletal muscle mass [121]. Muscle is a vast repository of stored glycogen, with approximately five times the glycogen content of liver tissue. In addition, glycogen content is higher in the skeletal muscle of trained versus untrained subjects, as muscle glycogen stores are replenished within 24 hours post training through increased glucose uptake [120,122]. Meta-analyses and reviews of the effect of resistance training on fasting blood glucose levels and resting metabolic rate show corresponding improvements in these parameters [4,110,118,123-128].

Resistance training improves hemoglobin A1C (HbA1C) concentrations in patients with evidence of insulin resistance, including type 2 diabetes, according to a systematic review of 23 trials involving 954 patients [126]. Strength training appears to be more effective than aerobic exercise for this purpose. As an example, in a randomized trial, 20 untrained subjects with type 2 diabetes were assigned to either treadmill or resistance training, each group training three times per week for 10 weeks [129]. Pre-intervention HbA1C measurements were 8.7 percent for the treadmill group and 8.9 percent for the resistance training group. After 10 weeks, none of the patients in the treadmill group attained an HbA1C level of 7 percent or less, while 40 percent of those in the resistance exercise group reached target HbA1C levels [129].

Resistance training may also reduce the risk of developing diabetes [127,130,131]. A review of the Health Professionals Follow-up Study, in which 32,002 men were observed over a period of 18 years, found that subjects engaging in resistance training greater than 150 minutes per week showed a 34 percent reduction in the risk for developing type 2 diabetes after adjustment for aerobic activities and body mass index [127,130].

Cardiovascular

Coronary artery disease and myocardial infarction — Resistance training is beneficial in patients with stable coronary artery disease. While it is typically studied in combination with aerobic training, resistance training independently increases muscle strength and endurance performance, and the combination of resistance and aerobic training outperforms aerobic-only training for outcomes including muscle strength, work capacity, maximal oxygen consumption (VO2 max), fat mass, and fat-free mass [132,133]. The data do not show an increased rate of adverse effects (dysrhythmia, worsening of ejection fraction, hypertension, or angina) resulting from resistance training, even in those undergoing cardiac rehabilitation following acute myocardial infarction [134]. Preliminary evidence in animal models suggests that prior routine resistance training may reduce the extent of ischemia-reperfusion injury in the setting of acute myocardial ischemia or infarction [135].

Cardiovascular disease risk factors — Resistance training appears to have a beneficial impact on several risk factors for cardiovascular disease. These include lowering blood pressure, reducing fasting serum glucose concentrations, improving insulin sensitivity and dyslipidemia, decreasing waist circumference, and improving body composition [40,86,96-100,136]. (See 'Hypertension' below and 'Diabetes' above and 'Obesity' above.)

Resistance training has a beneficial impact on dyslipidemia in the setting of type 2 diabetes. In one controlled trial over three months in which 56 obese type 2 diabetics were randomized to high-intensity resistance training (60 to 80 percent 1RM) versus no exercise, the resistance training group showed dramatic reductions in circulating ApoB concentration (from 135.92±30.97 mg/dL to 85.9±26.46 mg/dL) versus no change in the control group, with significant improvement in the ApoB/ApoA1 ratio as a consequence [137]. Similar results have been reported in nondiabetic individuals with obesity [136].

Hypertension — The conventional wisdom that progressive or heavy strength training increases resting blood pressure has long since been debunked. On balance, the available data indicate that strength training exerts beneficial effects in hypertensive patients, including decreases in systolic blood pressure (SBP) and diastolic blood pressure (DBP) [128,138]. In addition, in our clinical experience, subjects with hypertension who initiate a strength training program typically effect changes in their diet and lifestyle, further contributing to improvements in resting blood pressure.

A review of 33 randomized controlled trials (n = 1012) lasting at least four weeks showed reductions in SBP of 3.9 mmHg (CI -6.4 to -1.2) and in DBP of 3.9 mmHg (CI -5.6 to -2.2) among 28 normotensive or pre-hypertensive study groups [139,140]. However, only four of the included trials examined hypertensive individuals, and among these hypertensive study groups, the respective reductions of 4.1 and 1.5 mmHg for SBP and DBP did not reach statistical significance. A subsequent meta-analysis of five randomized trials (n = 201) analyzing the effect of resistance training performed for at least eight weeks on blood pressure changes exclusively in "pre-hypertensive" or hypertensive individuals reported significant reductions in SBP and DBP of 8.2 mmHg (CI -10.9 to -5.5) and 4.1 mmHg (CI -6.3 to -1.9), respectively [141].

Some researchers believe the antihypertensive mechanism of resistance training is distinct from that of aerobic training; specifically, there are data suggesting that resistance training produces a greater increase in peripheral vasodilatory capacity, increasing microvascular flow and capacitance [142].

Antihypertensive medication interactions — Antihypertensive medications exert diverse and wide-ranging physiological effects beyond lowering blood pressure. Their effects in the context of strength training and potential impact on training outcomes require due consideration by the clinician. A complete exposition of this issue is beyond the scope of the present article. Here, we focus attention on two commonly prescribed classes of antihypertensive agents, angiotensin-converting enzyme (ACE) inhibitors and beta blockers.

ACE inhibitors may enhance the hypertrophic response to strength training in older patients by modulating factors contributing to anabolic resistance. ACE inhibitors have been proposed as a therapeutic agent for sarcopenia, as they increase blood flow to skeletal muscle, promote more robust muscle protein synthesis, increase IGF-1 levels in response to activity, increase mitochondrial density in muscle, and decrease inflammatory processes associated with anabolic resistance [143,144].

The few trials examining the clinical effect of ACE inhibitors on training outcomes show mixed results. In an observational study of 2431 subjects age 70 to 79, those with hypertension who were being treated with an ACE inhibitor had significantly larger lower extremity muscle mass compared with those who used other medications [145]. However, the Berlin Aging Study-II (BASE-II) trial reported that community-dwelling older adults on ACE inhibitors had higher amounts of lean body mass relative to height but lower amounts of lean body mass relative to body mass. Additionally, ACE inhibitors did not produce a significant difference in timed "up and go" performance tests [146].

In contrast to ACE inhibitors, beta blockers tend to blunt the muscle protein synthesis response and increase protein oxidation, with the net effect of decreasing lean body mass [147-150]. Additional data from chronic beta blocker users indicate decreases in daily energy expenditure, decreased postprandial fat oxidation, and increased fat mass compared with controls [149,150]. Beta blockers may also blunt compensatory tachycardia during exercise [151]. Beta blockers are not considered first-line therapy for hypertension, and we suggest that alternative antihypertensive agents be considered for patients engaged in strength training if second- or third-line medications are warranted.

Heart failure — Patients with chronic heart failure have significant physical disability compared with age- and activity-matched controls due to deficits in both aerobic capacity and muscular strength [152,153]. Myocardial dysfunction induces neurohormonal, metabolic, and circulatory changes that result in an imbalance between anabolic and catabolic processes at the level of skeletal muscle, producing a progressive skeletal myopathy and ultimately a wasting syndrome. This myopathy contributes to the exercise intolerance observed in chronic heart failure.

There is growing evidence for the benefits of resistance training in both chronic systolic heart failure and chronic diastolic heart failure. These data indicate beneficial metabolic and functional adaptations in skeletal muscle, including improvements in skeletal muscle metabolism, increased muscle mass and strength, increased exercise tolerance, and increased VO2max (indicative of improved aerobic capacity and endurance) [154-156]. These adaptations have been reported with resistance exercise alone and in combination with aerobic exercise. However, evidence is limited in part by the highly variable interventions among studies, making conclusions about effect sizes unclear.

Despite widespread concern among physicians about harmful effects from the acute increase in afterload caused by resistance training, available evidence suggests that strength training does not cause adverse effects, such as reduction in ejection fraction, hypertension, dysrhythmia, or other cardiac dysfunction; and training in this population appears to be safe and beneficial. The role of strength training in patients with heart failure is reviewed in greater detail separately. (See "Cardiac rehabilitation in patients with heart failure", section on 'Resistance training'.)

Peripheral vascular disease — Patients with peripheral vascular disease have impaired muscle strength and walking ability, resulting in progressive functional impairment and poorer quality of life. Leg strength correlates in linear fashion with lower extremity ankle-brachial index and with functional performance in patients with peripheral arterial disease [157]. In patients with symptoms ranging from mild to severe claudication, resistance training using loads approaching 90 percent of 1RM induces vasodilation and reactive hyperemia as well as clinical improvements in maximal strength, VO2max, walking performance, stair-climbing ability, and quality of life without evidence of adverse effects such as worsening pain [158-162]. (See "Management of claudication due to peripheral artery disease", section on 'Exercise therapy'.)

Musculoskeletal — The most obvious impact of strength training is on the musculoskeletal system [163]. On balance, the data indicate that strength training has powerful effects against the loss of bone and muscle with concomitant beneficial effects on frailty, function, and metabolic health.

Sarcopenia — The progressive loss of muscle mass in aging adults is a physical, functional, and metabolic catastrophe. Sarcopenia predisposes to osteopenia, weakness, loss of function, and frailty. In addition, muscle tissue is increasingly recognized as both an endocrine organ and a major contributor to whole-body insulin sensitivity. Sarcopenia is therefore associated with insulin resistance, type 2 diabetes, and the metabolic syndrome, with the attendant increased risks of cardiovascular disease and stroke.

The sarcopenia of aging appears to be dominated by atrophy of large, high-powered, type II muscle fibers [164], which are precisely the fibers addressed by strength training. The results of multiple observational studies suggest that aging adults can slow, arrest, or reverse degenerative sarcopenia with resistance training [164-166].

Osteoarthritis — Osteoarthritis is one of the most common disabling conditions encountered in clinical practice, most often affecting the knees, hips, and hands of middle-aged and older individuals. Patients with knee osteoarthritis commonly show deficits in quadriceps muscle strength, which correlates strongly with both functional ability and pain. Chronic osteoarthritis pain has been associated with depression, poor psychological outlook, and decreased self-efficacy, all of which then perpetuate inactivity and further disability [167].

The available evidence shows that progressive resistance training induces clinically significant improvements in muscle strength, functional ability, and pain scores, even in patients with advanced disease [168]. Earlier intervention to attenuate the progressive loss of muscle strength associated with osteoarthritis may retard progression of disease. In addition, progressive resistance training improves patient self-efficacy, in part through pain reduction [167,169-172].

Due to the heterogeneity of interventions studied, evidence on the optimal prescription for resistance training in this population is mixed. As an example, positive results have been shown with isokinetic, concentric-only, and combined eccentric-concentric resistance programs. Some data suggest greater improvement with eccentric-concentric training, which tends to incorporate large multijoint movement patterns. Concerns over the feasibility of high-intensity resistance training in patients with symptomatic osteoarthritis have been challenged by studies showing the safety of intensities above 80 percent 1RM without exacerbation of pain symptoms. Higher-intensity training programs also tend to show greater effect sizes in improvements in strength, functional status, and decreases in pain [169-172].

Resistance training appears to be safe and may be beneficial in patients after joint arthroplasty, starting as early as the immediate postoperative period. Patients undergoing hip arthroplasty are typically of advanced age and often fail to regain their prior functional status due to the effects of perioperative immobilization and hospitalization. A small randomized trial comparing progressive resistance training (using 65 to 80 percent of the 1RM), percutaneous neuromuscular electrical stimulation, and conventional physiotherapy showed that of the three interventions, only progressive strength training resulted in decreased hospital length of stay, prevented postoperative muscular atrophy, and increased muscular strength when assessed at 12 weeks postoperatively [173].

Osteopenia and osteoporosis — The recommendation for weight-bearing exercise is well-accepted in the management of osteopenia and osteoporosis [174]. Mechanical loads that induce high strain rates or frequencies induce adaptive bone remodeling in a dose-dependent fashion [175]. Bone remodeling cycles require several months to complete, and radiographic changes in bone mineral density changes can take even longer to manifest on dual energy x-ray absorptiometry (DXA) [176]. However, most research has involved small sample sizes, short durations (eg, 12 weeks or less), or low- to moderate-load training, leading to modest results with a mean treatment effect of 0.3 percent for bone density at the hip or spine [177].

Better-designed trials report greater benefit. The 2017 Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation (LIFTMOR) trial studied an eight-month, high-intensity (80 to 85 percent 1RM) progressive resistance training program among 101 postmenopausal females with low or very low bone mass, 28 percent of whom had suffered an osteoporotic fracture within the prior 10 years [178]. Compared with the control group, which performed a traditional home-based, low-intensity program, the intervention group showed superior outcomes of bone mass, femoral neck geometry, and all measures of physical function. The lumbar spine and femoral neck bone density changes were 2.9 and 0.3 percent, respectively, versus -1.2 and -2.0 percent for the control group. No fractures occurred in the trial, although the trial was not powered or designed to specifically measure safety outcomes.

Back pain — Back pain is one of the most common complaints in the primary care setting. The large majority of back pain in this setting is nonspecific. Acute back pain (<4 weeks duration) has a good prognosis, with 70 to 90 percent resolving spontaneously within seven weeks. In general, exercise has not been shown to improve short-term outcomes in acute back pain compared with other conservative treatments. However, current guidelines suggest avoiding bedrest and staying as active as possible, including the maintenance of any existing exercise routine, if tolerated. For subacute (4 to 12 weeks) and chronic low back pain, the evidence in favor of exercise is stronger. (See "Treatment of acute low back pain" and "Exercise-based therapy for low back pain".)

While many studies focused on core strengthening exercises for the management of chronic low back pain have generated mixed or negative results, there is favorable evidence for resistance training. In a study of 45 adults with chronic low back pain, patients managed with a 16-week, whole-body, progressive resistance training program using a variety of free weight and machine-based exercises demonstrated improvements in strength, pain reduction, and quality-of-life measures not seen in patients managed with aerobic training [179]. Two similar studies by the same research group involving different populations with chronic low back pain have reported similar results [180,181].

Of note, evidence suggests that baseline psychosocial variables are stronger predictors of long-term pain and disability than structural findings on magnetic resonance imaging (MRI), which have only weak associations with long-term outcomes [182-184]. As an example, negative beliefs about back pain, fear-avoidance beliefs, kinesophobia (fear of movement), catastrophizing, and anxiety are associated with higher pain intensity, greater disability, and worse long-term outcomes. Clinicians' language and management approach have an important and underappreciated impact on these patient beliefs. The results of a survey study of 130 patients suggest that up to 89 percent of patients with persistent or recurrent low back pain learn their negative beliefs from health care professionals [184].

While it is important for clinicians to perform a careful assessment of acute or chronic back pain for high-risk features (eg, history of cancer or osteoporosis, signs of infection, neurologic deficits), it is also important to avoid inducing or exacerbating patients' negative beliefs and fears. These may result in increased pain intensity, duration, or disability stemming from a reluctance to be active, engage in exercise, or participate in rehabilitation activities. One of the primary mechanisms by which resistance exercise benefits patients with chronic back pain is by modulating these psychological factors. In one randomized trial of 49 obese adults with chronic low back pain, patients participating in a total-body resistance training program experienced greater reductions in perceived disability, pain catastrophizing, and pain severity than those following a specific lumbar extensor exercise program [185].

Intervertebral disc herniation — Little prospective evidence exists to assess any causal relationship between resistance training and back pain or intervertebral disc prolapse. Available evidence suggests that resistance training may be protective. In a case-control study comparing 287 patients with lumbar disc herniation versus controls matched by age and sex, individuals who had lifted weights at least 10 times within the prior two years had a relative risk for disc herniation of 0.90, whereas those who lifted the heaviest weights for two or more repetitions had a relative risk of 0.72 [186]. Several lines of evidence suggest that the spine and its associated structures are capable of adaptation in response to repeated axial loading over long periods [56,187].

Gastroenterology

Cirrhosis — Cirrhosis is characterized by a number of complex metabolic alterations that affect muscle growth and contribute to atrophy. Sarcopenia is among the most frequent complications of cirrhosis and is most severe in patents with alcohol-related and cholestatic diseases [188]. Sarcopenia is compounded by malnutrition and dietary protein restriction as well as by certain medications. These include glucocorticoids or, in the post-transplant population, other immunosuppressants (eg, sirolimus) that directly inhibit the mTOR signaling pathway (a primary driver of muscle protein synthesis). Sarcopenia and the associated loss of function is a major contributor to diminished quality of life in these patients.

Studies of resistance training in the setting of cirrhosis are limited, and theoretical concern exists about increases in portal pressures from exercise, which may pose risks in patients with complications from portal hypertension. A 2018 systematic review on physical exercise in patients with cirrhosis identified six randomized trials ranging in length from 8 to 14 weeks, only one of which studied resistance training alone and two of which studied combined aerobic and resistance training [189]. Based on this limited and generally low-quality evidence, this review was unable to show clear benefit or harm. However, several small studies not considered in the review have shown significant improvements in muscle mass, strength, functional capacity, quality of life, and fatigue as well as reductions in the hepatic venous pressure gradient without apparent adverse events [190]. Further study is needed to determine the appropriate role of strength training for patients with this complex and common condition.

Nonalcoholic fatty liver disease — Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in industrialized countries. It is frequently associated with central obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome; and it may progress to cirrhosis, leading to substantial morbidity and mortality. Treatment of NAFLD emphasizes weight loss through diet and exercise. Several randomized trials report that resistance exercise reduces liver fat and improves other findings associated with NAFLD [191-193]. According to a 2017 systematic review of studies comparing aerobic versus resistance exercise for the management of NAFLD, both types were found to reduce hepatic steatosis, but energy consumption was lower for resistance training [194]. The authors of the review suggest that resistance exercise may be better suited to NAFLD patients with poor cardiorespiratory fitness. (See "Management of nonalcoholic fatty liver disease in adults".)

Pulmonary — Limited data exist concerning the impact of resistance training on pulmonary function and disease. We restrict the present discussion to chronic obstructive pulmonary disease (COPD), the best-studied condition in the context of strength training. (See "Pulmonary rehabilitation", section on 'Exercise training'.)

COPD has a number of known extrapulmonary effects, including weight loss, progressive skeletal muscle dysfunction, and atrophy. Historically, these were thought to result from patient inactivity due to dyspnea with exertion. However, it is now recognized as a multifactorial process also involving systemic corticosteroid exposure, chronic hypoxemia, systemic inflammation, and oxidative stress [195-197]. These factors result in various structural, metabolic, and functional changes that directly impair muscle function while also inducing an imbalance between anabolic and catabolic processes that result in progressive muscle wasting. These findings have led some authors to suggest that the muscle dysfunction observed in COPD results not only from disuse but also from an intrinsic myopathy. In fact, some evidence suggests that maximal voluntary contraction force of the quadriceps is a more powerful predictor of mortality in patients with COPD than age or forced expiratory volume in one second (FEV1) [198].

Muscle dysfunction influences patient symptoms, functional capacity, quality of life, health care utilization, and overall mortality in patients with COPD. Conversely, resistance training in patients with COPD reduces markers of systemic inflammation, increases muscle strength and hypertrophy, improves muscle endurance, and improves functional capacity and quality of life [199]. Although evidence is limited by variation among interventions, intensity, and duration, training patients with COPD does not appear to affect respiratory function directly.

In the acute setting of COPD exacerbation, resistance training appears to be feasible, prevents deterioration of skeletal muscle function, and improves anabolic signaling without evidence of adverse effects [200]. In addition, resistance training may be more feasible in patients who are limited by dyspnea and therefore unable to perform the extended bouts of traditional aerobic training often involved in pulmonary rehabilitation.

Rheumatology and immunology — Data on resistance training in the setting of autoimmune diseases such as the seronegative spondyloarthropathies, systemic lupus erythematosus, polymyalgia rheumatica, the autoimmune myopathies, and inflammatory bowel disease are quite limited. The effects of strength training on rheumatoid arthritis (RA) are best understood.

As with all chronic inflammatory conditions, RA causes interference with anabolic signaling, resulting in progressive muscle wasting and dysfunction ("rheumatoid cachexia") [201]. Reductions in strength ranging from 25 to 70 percent have been observed in patients with RA compared with healthy age-matched controls. Reductions in strength occur out of proportion to losses in total muscle bulk, likely reflecting intrinsic muscular dysfunction. This progressive functional impairment combined with joint pain promotes inactivity and further disability [202].

In patients with RA, progressive resistance training increases muscle strength and muscle hypertrophy, improves overall functional capacity, and helps address other disease complications such as osteoporosis, dyslipidemia, and insulin resistance. In particular, higher-intensity interventions have been shown to have greater effects than low-intensity interventions, without exacerbating joint pain or disease activity in individuals with controlled disease [203-206]. (See 'Osteopenia and osteoporosis' above and 'Cardiovascular disease risk factors' above.)

Renal — Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) produce a chronic inflammatory state associated with various adverse metabolic and neurohormonal changes. These changes induce resistance to anabolic stimuli by modulating cell signaling mechanisms involved in muscle protein synthesis and breakdown [207]. The resultant hypercatabolic state results in chronic muscle wasting (sarcopenia), bone loss, and functional decline, which is further exacerbated by inactivity and by the institution of a low-protein diet in the setting of CKD. (See "Overview of the management of chronic kidney disease in adults" and "Osteoporosis in patients with chronic kidney disease: Diagnosis and evaluation" and "Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD)" and "Chronic kidney disease and coronary heart disease".)

The importance of exercise, and resistance training in particular, is underemphasized among patients with CKD/ESKD despite a growing body of evidence showing clinically meaningful benefit in this population. Evidence from randomized clinical trials shows that progressive resistance training increases muscular strength and hypertrophy, improves health-related quality of life, and prevents the catabolic effects of a low-protein diet in CKD and ESKD patients [208-211]. The data for other outcomes are mixed, limited primarily by trial design, including small sample sizes, short durations (eg, 8 to 12 weeks or less), timing of intervention (intra- versus inter-dialysis), and low-intensity interventions. Given the current understanding of the pathophysiology of anabolic resistance in healthy aging populations, the changes associated with CKD suggest that low- to moderate-intensity interventions are less likely than higher-intensity training to induce the anabolic responses necessary to reverse muscle wasting and bone mineral density losses.

It is critical to note that the healthy resistance-trained individual may develop and carry greater skeletal muscle mass relative to their untrained counterparts. This increased muscle mass results in an increase in baseline serum creatinine levels, often outside the traditional reference range. Such increases should not be interpreted as evidence of renal injury induced by resistance training. (See "Assessment of kidney function".)

Neurology — While the role of resistance training in the treatment of common conditions (eg, migraine) and the rehabilitation of neurodegenerative disorders is attracting increased attention, data remain incomplete.

Migraine — A 2022 systematic review and network meta-analysis evaluated 21 controlled trials of interventions for migraine prevention [212]. While all exercise interventions were more effective than the control for reducing migraine frequency, strength training had the largest effect size (mean monthly migraine days -3.55, 95% CI -5.28 to -0.97), followed by high-intensity aerobic exercise (-3.13, 95% CI -5.28 to -0.97) and moderate-intensity aerobic exercise (-2.18, 95% CI -3.25 to -1.11), followed in turn by topiramate (-0.98, 95% CI -4.16 to 2.20), placebo, and amitriptyline. There was no relationship between the muscles targeted by strength training exercises (eg, neck or shoulder muscles) and the observed clinical benefit.

Stroke — Stroke is a leading cause of chronic disability, often due to muscle weakness and hemiparesis. This disability results in progressive functional impairment, inactivity, and immobilization, particularly of the hemiparetic limb. Emerging evidence shows a number of structural and metabolic changes at the level of skeletal muscle after acute stroke, including atrophy, alterations in myosin expression, chronic inflammatory signaling, and consequent oxidative damage [213]. These changes result in progressive wasting, impaired function, and disability.

Most stroke rehabilitation occurs in the subacute phase, and there is little guidance on exercise thereafter. Available evidence suggests that progressive resistance training is feasible, safe, and effective for improving muscle strength and reducing functional limitations in both paretic and non-paretic extremities in patients with chronic stroke [214-217]. Higher-intensity interventions tend to produce greater effects, and several studies have shown strength improvements to be persistent at long-term follow-up [218]. The available data are generally limited by highly variable resistance training interventions, timing of intervention, and follow-up; the optimal timing and prescription for these interventions have therefore not been established.

Parkinson disease — The role of resistance training for improvement of function in patients with Parkinson disease has drawn considerable attention. Although this body of work is incomplete and methodologically limited, on balance, the data indicate that training for strength is safe, feasible, and beneficial in this population [219-221]. A 2013 meta-analysis found evidence for improvements in strength and walking performance but not for other physical performance outcomes [222]. Another 2013 meta-analysis reported improvements in strength, fat-free mass, endurance, mobility, and performance in functional tasks [223]. Individual studies suggest improvements in postural control and gait initiation [224], bradykinesia [225], and overall physical function [226]. Individual responses to training are likely to vary widely, and strength and conditioning professionals must work closely with clinicians and patients to tailor programs to individual needs and limitations. We find no compelling evidence that training has a meaningful impact on the underlying neurodegenerative pathophysiology of Parkinson disease. (See "Nonpharmacologic management of Parkinson disease".)

Psychiatry — A 2018 systematic review and meta-analysis of 33 trials on the effects of resistance training on depressive symptoms found evidence of a significant reduction in symptoms, with a moderate effect size [227]. A 2017 meta-analysis of 17 studies showed resistance training to have a significant effect on reducing symptoms of anxiety in both healthy patients and those with diagnosed mental illness [228]. Effect sizes were greater for reducing symptoms in healthy patients but otherwise did not vary based on whether strength ultimately improved as a result of training, suggesting an independent mechanism of benefit outside of muscular strengthening. (See "Complementary and alternative treatments for anxiety symptoms and disorders: Physical, cognitive, and spiritual interventions", section on 'Physical activities'.)

WHAT ARE THE RISKS OF STRENGTH TRAINING? — We recommend that strength training be conducted with carefully titrated loads and judicious progression, on stable surfaces, and without exposure to impacts or unexpected or impulsive joint forces or moments. When so administered, strength training is extremely safe [16,229-231]. When injuries or acute pathologic conditions are sustained from strength training, these often can be attributed to poor programming or technique used by the trainee or trainer.

The risks of any particular strength training program for any particular patient are primarily due to individual patient attributes, exercise selection, progression, equipment, coaching, and the overall model of training. A complete examination of this topic is beyond the scope of the present discussion. Here we take a systems-based approach to discussing some of the specific risks that must be managed in any strength training program.

Cardiovascular disease — While habitual resistance exercise provides numerous benefits as described above, such activity can acutely and transiently increase the risk of sudden cardiac death and acute myocardial infarction in individuals at risk. Among individuals below 30 to 40 years of age, these risks most commonly involve hereditary or congenital heart disease (structural, coronary, valvular, or conduction system disease). Among older individuals, such risks are most often related to coronary artery disease, resulting in acute plaque rupture or malignant cardiac arrhythmias.

Coronary artery disease — For patients with coronary artery disease, many clinicians have concerns regarding the hemodynamic changes during resistance exercise precipitating a cardiovascular event. Most of the available data describing these risks are in the context of general exercise rather than resistance training specifically. The rate of exercise-induced cardiovascular events in young athletes and in ostensibly healthy adults is extremely low. However, vigorous exercise (typically defined as >6 metabolic equivalents [METs]; equivalent to jogging) increases cardiovascular risk during or immediately after exercise in young individuals with inherited disease and adults with occult or known cardiovascular disease.

Despite growing evidence demonstrating the benefits of resistance training in the setting of stable coronary disease, a 2017 meta-analysis found that reporting of adverse cardiac events was poor, with notable gaps in reporting for females, older adults, and long-term outcomes for high-intensity, progressive resistance training [232]. Based on the available evidence, for patients with asymptomatic coronary disease, the benefits of resistance training appear to outweigh the risks. Patients with stable angina should avoid exercise intensities that provoke symptoms, while patients with unstable or progressive symptoms should abstain from exercise and seek immediate medical attention. (See 'Coronary artery disease and myocardial infarction' above.)

Hypertension — Risks of resistance training in the setting of hypertension reflect many of the same concerns discussed above related to coronary artery disease. According to the American College of Sports Medicine (ACSM) guidelines, only high-risk individuals with hypertension (symptomatic hypertension or those with known cardiovascular, pulmonary, renal, or metabolic disease) who are planning to engage in moderate- to high-intensity exercise are recommended to undergo medical evaluation prior to exercise. However, there is no evidence demonstrating an increased risk of adverse events during exercise secondary to exercise-induced hypertension. Similarly, the available evidence does not show a significant effect of resistance training on blood pressure for up to 24 hours after an exercise session. Of note, the American Heart Association (AHA) considers a resting systolic blood pressure (SBP) >200 mmHg or diastolic blood pressure (DBP) >110 mmHg to be a relative contraindication to exercise stress testing [233-235].

Cardiovascular medications — Patients with cardiovascular disease are commonly prescribed a number of medications that may have implications for exercise in general and for resistance training in particular.

Lipid-lowering agents, such as statins and fibrates, predispose to myalgias, myopathy, and rarely, rhabdomyolysis. Fortunately, these complications are relatively uncommon. A patient initiating a resistance training program may experience delayed-onset muscle soreness in the early phases of training. This is a brief, self-limited condition and should not be interpreted as a medication side effect. Training should be initiated and progressed gradually, and unusually persistent or worsening muscle soreness associated with edema, dark urine, or other complaints concerning for rhabdomyolysis should be referred for immediate evaluation and treatment. A history of rhabdomyolysis does not represent a contraindication to the subsequent initiation of resistance training. (See "Statin muscle-related adverse events" and "Rhabdomyolysis: Clinical manifestations and diagnosis".)

Antihypertensives have several important considerations pertaining to resistance training. Diuretics increase the risk of dehydration and hypovolemia, which can impair performance and the physiologic response to training but also increase the risk of orthostasis, falls, and renal insufficiency. Attention should therefore be paid to ensuring adequate hydration before and during exercise sessions for patients on diuretics. Beta blockers and nondihydropyridine-type calcium channel blockers impair the chronotropic response to exercise and may therefore limit physical performance but also serve to limit the increase in rate-pressure product during exercise, which may prevent angina in susceptible patients with coronary artery disease. (See "Exercise in the treatment and prevention of hypertension".)

There is insufficient direct evidence to inform recommendations concerning resistance training in post-aortic dissection patients or in patients with ventricular or arterial aneurysm or known uncorrected cerebrovascular anomalies. The majority of recommendations advise against high-load resistance training or training to failure due to the acute increases in blood pressure that occur during these activities [236]. Pending further study, we concur with these recommendations.

Endocrine-metabolic — The risks of resistance training in patients with diabetes include hypoglycemia and hyperglycemia, complications of coronary artery disease, complications of proliferative retinopathy, and potential musculoskeletal injuries due to peripheral or autonomic neuropathy.

Patients with type 2 diabetes are commonly prescribed oral or injectable hypoglycemic medications, while patients with type 1 diabetes usually take injectable insulins or continuous insulin pump therapy. Exercise-induced hypoglycemia (both immediate and post-exercise hypoglycemia) is common among patients with type 1 diabetes and, to a lesser extent, those with type 2 diabetes. Reductions in basal and/or bolus insulin therapy, as well as strategic ingestion of peri-workout carbohydrate, may be required to avoid this effect [110]. The hypoglycemic response to exercise among diabetics varies widely, and therefore, it is important to monitor serum glucose closely when initiating a strength training program. (See "Hypoglycemia in adults with diabetes mellitus", section on 'Exercise-induced hypoglycemia'.)

Diabetes is a cardiac risk equivalent, and there is a high incidence of coronary artery disease in this population. In addition, patients with microvascular complications of diabetes appear to have an impaired cardiovascular response to exercise. Therefore, it is important to be aware of the patient’s cardiac status prior to engaging in exercise due to the risk for ischemia and dysrhythmia. (See 'Coronary artery disease and myocardial infarction' above.)

Overall, exercise does not appear to accelerate the development or progression of diabetic retinopathy, and exercise-related improvements in glycemic control could conceivably reduce the risk of retinopathy. However, in the setting of established, advanced proliferative diabetic retinopathy, acute exercise-induced elevations in blood pressure may precipitate hemorrhagic complications due to impaired autoregulation of ocular blood flow. Unfortunately, there is no clear threshold for SBP above which the risk of hemorrhagic complications increases and below which intense resistance exercise is deemed safe [237].

Patients with peripheral or autonomic neuropathy may be at increased risk for falls and orthostatic hypotension during exercises performed while standing or those that involve significant changes in body position, and this should be considered when designing and executing a strength training program.

Musculoskeletal

General risk — Like any form of exercise, resistance training poses a risk of acute musculoskeletal injury, such as muscle strain, tendon sprain or rupture, ligament tear, and acute low back pain. Resistance training may also result in acute exacerbation of pain from chronic conditions, such as tendinopathy, osteoarthritis, and other rheumatologic ailments. The shoulder, low back, knee, elbow, and wrist are most commonly affected.

Literature is limited, and adverse events tend to be under-reported in studies of resistance training [238]. However, the available evidence and our clinical experience suggest that rates of musculoskeletal injury among participants in well-designed and properly coached programs are extremely low. This is supported by studies of injury rates among participants in competitive strength sports. As an example, a 2017 systematic review of studies of competitive weightlifters and powerlifters, sports contested using one-repetition maximum (1RM) loads, reported rates of approximately 2.4 to 3.3 injuries and 1.0 to 4.4 injuries per 1000 participation hours, respectively, which are low compared with those observed in most team sports [239]. In another systematic review, bodybuilding was reported to have an injury rate of 0.12 to 0.7 injuries per lifter per year, or 0.24 to 1.0 injury per 1000 participation hours [240].

Recreational strength training among the general population involves lower volumes, less frequency, and lower intensity compared with competitive strength athletes. If doses are appropriately prescribed and adjusted for baseline fitness levels, it is reasonable to conclude that musculoskeletal injury risk in this context is low. From this perspective, the many benefits of resistance training discussed above outweigh such risks.

Reducing risk — Most exercise-related injuries are multifactorial and may relate to the type and volume of activity, individual factors (eg, baseline fitness and health status), and environmental conditions. According to the Scientific Report from the United States Physical Activity Guidelines, the risk of activity-related injury is directly related to a person’s usual amount of physical activity; when individuals increase their amount of activity, injury risk relates to the size of this increase [241]. Therefore, prescribing an appropriate dose of exercise relative to the individual's habitual level of activity, and increasing this dose gradually, provides the most effective means for reducing injury risk. (See "Practical guidelines for implementing a strength training program for adults", section on 'Implementing a strength training program'.)

Back pain — As discussed above, patients with acute or subacute low back pain, with or without radiculopathy, are likely to improve over time regardless of treatment [242]. Bedrest is ineffective and appears to be inferior to staying active for reducing pain and improving functional outcomes [243,244].

Although available evidence is not specifically focused on resistance training, exercise does not appear to increase the risk of low back pain exacerbations compared with nonexercising control populations. Limited evidence suggests that strength training does not increase the risk for intervertebral disc herniation and may be protective. (See 'Back pain' above and "Acute lumbosacral radiculopathy: Treatment and prognosis".)

Available evidence pertaining to the role of exercise for low back pain, combined with the extensive health benefits of resistance training, suggests that initiation or continuation of resistance exercise is a reasonable approach for these patients, depending on individual patient preference and other factors. Patients without high-risk features of low back pain should be encouraged to participate in graded exercise to improve self-efficacy, reduce kinesophobia, and obtain the numerous other health benefits of exercise described above. Exercise type, frequency, and intensity should be modified based on the patient's symptoms and tolerance. (See "Evaluation of low back pain in adults" and "Exercise-based therapy for low back pain" and "Practical guidelines for implementing a strength training program for adults".)

Rhabdomyolysis — Rhabdomyolysis is a syndrome in which skeletal muscle breakdown leads to release of intracellular muscle contents into the circulation [245,246]. Prolonged strenuous muscular exertion far in excess of an individual's level of training adaptation increases the risk of exertional rhabdomyolysis. In particular, risk increases when the exercise is unfamiliar, repetitive, or involves numerous eccentric (muscle-lengthening) contractions [247]. Rhabdomyolysis unrelated to trauma is uncommon, with an incidence of 29.9 per 100,000 patient-years, though the specific contribution from strength training is not known [246].

Rhabdomyolysis is characterized clinically by myalgias, red to brown urine due to myoglobinuria, and elevated serum muscle enzyme concentrations (eg, creatine kinase). The severity of rhabdomyolysis ranges from asymptomatic, self-limited elevations in serum muscle enzymes and mild myalgia after exercise (eg, delayed-onset muscle soreness) to life-threatening disease associated with extreme serum enzyme elevations, electrolyte imbalances, and acute kidney injury [245]. (See "Rhabdomyolysis: Clinical manifestations and diagnosis".)

It is important to identify those who may be at elevated risk for developing exertional rhabdomyolysis. Factors that increase risk include:

Patient or athlete is new to strength training or beginning a new, more demanding program

Patient is returning to strength training after an injury, illness, or prolonged absence

Strength training is to be performed in conditions of high heat and humidity

Genetic factors, including sickle cell disease or trait, inherited myopathy, or other muscle enzyme deficiencies/mitochondrial defects [248]

Personal or family history of malignant hyperthermia or rhabdomyolysis

Other risk factors for exertional rhabdomyolysis include the use of medications or supplements with sympathomimetic effects, recent systemic infection, and certain metabolic diseases [247,249]. (See "Rhabdomyolysis: Epidemiology and etiology".)

Despite the increased risk of exertional rhabdomyolysis in these populations, no guidelines suggest that training is contraindicated for them. The risks and benefits of strength training in these populations should be assessed on a case-by-case basis by the clinician and discussed with the patient.

Exertional rhabdomyolysis can be avoided easily by following appropriate precautions, including proper hydration and sensible programming that emphasizes gradual, incremental increases in training volume, intensity, and exposure to new movements. The principles and implementation of a proper strength training program are reviewed separately. (See 'Strength training: Definition and key principles' above and "Practical guidelines for implementing a strength training program for adults".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Exercise in adults".)

SUMMARY AND RECOMMENDATIONS

Definitions and key principles – Muscular strength is the ability to produce force against a resistance and thus is a fundamental fitness attribute that influences all others, including power, endurance, mobility, and balance. In addition, increased muscular strength protects against injury and frailty. (See 'What is strength and why is it important?' above.)

Strength (or resistance) training is a rational, explicit program of carefully chosen exercises performed over an extended period and designed to increase the subject's ability to produce muscular force in useful movement patterns. This goal cannot be realized by sporadic, unplanned, random bouts of exercise.

The Stress-Recovery-Adaptation model provides a useful conceptual framework for strength training programs. Training stress is based on the principle of progressive overload, a steady increase in the applied training stress, which produces a corresponding increase in physiologic and performance adaptation. Recovery and adaptation depend upon proper nutrition, adequate sleep, active rest between training days, and stress management. (See 'Strength training: Definition and key principles' above.)

Benefits – The benefits of properly performed strength training are myriad, including increased strength and power, improved body composition (eg, reduced visceral fat, increased lean muscle mass and bone density), increased anaerobic capacity, improved energy metabolism (eg, increased insulin sensitivity), and improvements in a host of risk factors for cardiovascular disease. (See 'What are the benefits of strength training?' above.)

In addition to its general health benefits, properly performed strength training can help to prevent or improve many medical conditions, including diabetes, cardiovascular disease, sarcopenia, and osteoporosis. These effects are discussed in detail in the text. (See 'What medical conditions improve with strength training?' above.)

Risks – Strength training should be performed with carefully titrated loads and judicious progression, on stable surfaces, and without exposure to impacts or unexpected or impulsive joint forces or moments. When so administered, strength training is extremely safe. However, as with any strenuous physical activity, participants entail some risk. These risks are described in the text. (See 'What are the risks of strength training?' above.)

  1. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009; 301:2024.
  2. Bird SP, Tarpenning KM, Marino FE. Designing resistance training programmes to enhance muscular fitness: a review of the acute programme variables. Sports Med 2005; 35:841.
  3. Faigenbaum AD, Myer GD. Resistance training among young athletes: safety, efficacy and injury prevention effects. Br J Sports Med 2010; 44:56.
  4. Westcott WL. Resistance training is medicine: effects of strength training on health. Curr Sports Med Rep 2012; 11:209.
  5. Winter EM, Abt G, Brookes FB, et al. Misuse of "Power" and Other Mechanical Terms in Sport and Exercise Science Research. J Strength Cond Res 2016; 30:292.
  6. American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 2009; 41:687.
  7. Shumway-Cook A, Anson D, Haller S. Postural sway biofeedback: its effect on reestablishing stance stability in hemiplegic patients. Arch Phys Med Rehabil 1988; 69:395.
  8. Fleck SJ, Falkel JE. Value of resistance training for the reduction of sports injuries. Sports Med 1986; 3:61.
  9. Lauersen JB, Andersen TE, Andersen LB. Strength training as superior, dose-dependent and safe prevention of acute and overuse sports injuries: a systematic review, qualitative analysis and meta-analysis. Br J Sports Med 2018; 52:1557.
  10. Cesari M, Landi F, Vellas B, et al. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci 2014; 6:192.
  11. Frisoli A Jr, Chaves PH, Ingham SJ, Fried LP. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women's Health and Aging Study (WHAS) II. Bone 2011; 48:952.
  12. Morley JE, von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle 2014; 5:5.
  13. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31:652.
  14. Bigland-Ritchie B, Woods JJ. Changes in muscle contractile properties and neural control during human muscular fatigue. Muscle Nerve 1984; 7:691.
  15. Rippetoe M, Baker A. Practical Programming for Strength Training, The Aasgaard Co, Wichita Falls, TX 2004.
  16. Sullivan J, Baker A. The Barbell Prescription: Strength Training for Life After Forty, The Aasgaard Co, Whichita Falls ,TX 2016.
  17. Kraemer WJ, Ratamess NA. Fundamentals of resistance training: progression and exercise prescription. Med Sci Sports Exerc 2004; 36:674.
  18. Kraemer WJ, Ratamess NA, Flanagan SD, et al. Understanding the Science of Resistance Training: An Evolutionary Perspective. Sports Med 2017; 47:2415.
  19. SELYE H. Stress and the general adaptation syndrome. Br Med J 1950; 1:1383.
  20. Fleck S, Kraemer W. Designing Resistance Training Programs, 4th ed, Human Kinetics, Champaigne 2014.
  21. Jubrias SA, Esselman PC, Price LB, et al. Large energetic adaptations of elderly muscle to resistance and endurance training. J Appl Physiol (1985) 2001; 90:1663.
  22. Brooks GA, Mercier J. Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. J Appl Physiol (1985) 1994; 76:2253.
  23. Tremblay A, Simoneau JA, Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism 1994; 43:814.
  24. Tesch PA, Colliander EB, Kaiser P. Muscle metabolism during intense, heavy-resistance exercise. Eur J Appl Physiol Occup Physiol 1986; 55:362.
  25. McArdle A, Jackson MJ. Exercise, oxidative stress and ageing. J Anat 2000; 197 Pt 4:539.
  26. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008; 88:1243.
  27. Stanford KI, Goodyear LJ. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ 2014; 38:308.
  28. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 2013; 93:993.
  29. Houmard JA, Tanner CJ, Slentz CA, et al. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol (1985) 2004; 96:101.
  30. Koopman R, Manders RJ, Zorenc AH, et al. A single session of resistance exercise enhances insulin sensitivity for at least 24 h in healthy men. Eur J Appl Physiol 2005; 94:180.
  31. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12:789.
  32. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine position stand. Exercise and type 2 diabetes. Med Sci Sports Exerc 2000; 32:1345.
  33. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011; 305:1790.
  34. Yang Z, Scott CA, Mao C, et al. Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis. Sports Med 2014; 44:487.
  35. Aune D, Norat T, Leitzmann M, et al. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol 2015; 30:529.
  36. Dutheil F, Lac G, Lesourd B, et al. Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE randomized trial. Int J Cardiol 2013; 168:3634.
  37. Schjerve IE, Tyldum GA, Tjønna AE, et al. Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults. Clin Sci (Lond) 2008; 115:283.
  38. Fleck SJ. Cardiovascular adaptations to resistance training. Med Sci Sports Exerc 1988; 20:S146.
  39. Moraes MR, Bacurau RF, Casarini DE, et al. Chronic conventional resistance exercise reduces blood pressure in stage 1 hypertensive men. J Strength Cond Res 2012; 26:1122.
  40. Ho SS, Dhaliwal SS, Hills AP, Pal S. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health 2012; 12:704.
  41. Goldberg AP. Aerobic and resistive exercise modify risk factors for coronary heart disease. Med Sci Sports Exerc 1989; 21:669.
  42. Liu-Ambrose T, Nagamatsu LS, Graf P, et al. Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med 2010; 170:170.
  43. Singh NA, Stavrinos TM, Scarbek Y, et al. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci 2005; 60:768.
  44. Nagamatsu LS, Handy TC, Hsu CL, et al. Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. Arch Intern Med 2012; 172:666.
  45. http://journals.sagepub.com/doi/abs/10.1177/1559827610368771 (Accessed on June 25, 2018).
  46. Gates N, Fiatarone Singh MA, Sachdev PS, Valenzuela M. The effect of exercise training on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials. Am J Geriatr Psychiatry 2013; 21:1086.
  47. Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA 2020; 324:1855.
  48. Ahtiainen JP, Walker S, Peltonen H, et al. Heterogeneity in resistance training-induced muscle strength and mass responses in men and women of different ages. Age (Dordr) 2016; 38:10.
  49. Churchward-Venne TA, Tieland M, Verdijk LB, et al. There Are No Nonresponders to Resistance-Type Exercise Training in Older Men and Women. J Am Med Dir Assoc 2015; 16:400.
  50. Pickering C, Kiely J. Do Non-Responders to Exercise Exist-and If So, What Should We Do About Them? Sports Med 2019; 49:1.
  51. Hagstrom AD, Marshall PW, Halaki M, Hackett DA. The Effect of Resistance Training in Women on Dynamic Strength and Muscular Hypertrophy: A Systematic Review with Meta-analysis. Sports Med 2020; 50:1075.
  52. Grgic J, Garofolini A, Orazem J, et al. Effects of Resistance Training on Muscle Size and Strength in Very Elderly Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Sports Med 2020; 50:1983.
  53. Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev 2010; 9:226.
  54. Waters DL, Baumgartner RN, Garry PJ, Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010; 5:259.
  55. Kelley GA, Kelley KS, Tran ZV. Resistance training and bone mineral density in women: a meta-analysis of controlled trials. Am J Phys Med Rehabil 2001; 80:65.
  56. Bemben DA, Bemben MG. Dose-response effect of 40 weeks of resistance training on bone mineral density in older adults. Osteoporos Int 2011; 22:179.
  57. Hinton PS, Nigh P, Thyfault J. Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trial. Bone 2015; 79:203.
  58. Tabata I, Nishimura K, Kouzaki M, et al. Effects of moderate-intensity endurance and high-intensity intermittent training on anaerobic capacity and VO2max. Med Sci Sports Exerc 1996; 28:1327.
  59. Tanaka H, Swensen T. Impact of resistance training on endurance performance. A new form of cross-training? Sports Med 1998; 25:191.
  60. Paavolainen L, Häkkinen K, Hämäläinen I, et al. Explosive-strength training improves 5-km running time by improving running economy and muscle power. J Appl Physiol (1985) 1999; 86:1527.
  61. Kraemer WJ, Ratamess NA, French DN. Resistance training for health and performance. Curr Sports Med Rep 2002; 1:165.
  62. Hickson RC, Rosenkoetter MA, Brown MM. Strength training effects on aerobic power and short-term endurance. Med Sci Sports Exerc 1980; 12:336.
  63. Ishii T, Yamakita T, Sato T, et al. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care 1998; 21:1353.
  64. Alvehus M, Boman N, Söderlund K, et al. Metabolic adaptations in skeletal muscle, adipose tissue, and whole-body oxidative capacity in response to resistance training. Eur J Appl Physiol 2014; 114:1463.
  65. https://link.springer.com/article/10.1007/s11556-013-0120-1 (Accessed on June 25, 2018).
  66. Frontera WR, Meredith CN, O'Reilly KP, Evans WJ. Strength training and determinants of VO2max in older men. J Appl Physiol (1985) 1990; 68:329.
  67. Vincent KR, Braith RW, Feldman RA, et al. Improved cardiorespiratory endurance following 6 months of resistance exercise in elderly men and women. Arch Intern Med 2002; 162:673.
  68. Ades PA, Ballor DL, Ashikaga T, et al. Weight training improves walking endurance in healthy elderly persons. Ann Intern Med 1996; 124:568.
  69. Hoff J, Gran A, Helgerud J. Maximal strength training improves aerobic endurance performance. Scand J Med Sci Sports 2002; 12:288.
  70. Beattie K, Kenny IC, Lyons M, Carson BP. The effect of strength training on performance in endurance athletes. Sports Med 2014; 44:845.
  71. Hubal MJ, Gordish-Dressman H, Thompson PD, et al. Variability in muscle size and strength gain after unilateral resistance training. Med Sci Sports Exerc 2005; 37:964.
  72. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 2001; 33:S446.
  73. Marcus RL, Smith S, Morrell G, et al. Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. Phys Ther 2008; 88:1345.
  74. Sparks LM, Johannsen NM, Church TS, et al. Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes. J Clin Endocrinol Metab 2013; 98:1694.
  75. Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: A narrative review. Eur J Intern Med 2015; 26:303.
  76. Stamatakis E, Lee IM, Bennie J, et al. Does Strength-Promoting Exercise Confer Unique Health Benefits? A Pooled Analysis of Data on 11 Population Cohorts With All-Cause, Cancer, and Cardiovascular Mortality Endpoints. Am J Epidemiol 2018; 187:1102.
  77. Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med 2022; 56:755.
  78. Ortega FB, Silventoinen K, Tynelius P, Rasmussen F. Muscular strength in male adolescents and premature death: cohort study of one million participants. BMJ 2012; 345:e7279.
  79. Ling CH, Taekema D, de Craen AJ, et al. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ 2010; 182:429.
  80. Li R, Xia J, Zhang XI, et al. Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults. Med Sci Sports Exerc 2018; 50:458.
  81. Gorzelitz J, Trabert B, Katki HA, et al. Independent and joint associations of weightlifting and aerobic activity with all-cause, cardiovascular disease and cancer mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Sports Med 2022; 56:1277.
  82. Sundell J. Resistance Training Is an Effective Tool against Metabolic and Frailty Syndromes. Adv Prev Med 2011; 2011:984683.
  83. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985) 2005; 98:1154.
  84. Peterson JM, Mart R, Bond CE. Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Fibronectin type III domain containing 5. PeerJ 2014; 2:e605.
  85. Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 2006; 57 Suppl 10:43.
  86. Curioni CC, Lourenço PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond) 2005; 29:1168.
  87. Khalafi M, Malandish A, Rosenkranz SK, Ravasi AA. Effect of resistance training with and without caloric restriction on visceral fat: A systemic review and meta-analysis. Obes Rev 2021; 22:e13275.
  88. Willis LH, Slentz CA, Bateman LA, et al. Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol (1985) 2012; 113:1831.
  89. Murton AJ, Marimuthu K, Mallinson JE, et al. Obesity Appears to Be Associated With Altered Muscle Protein Synthetic and Breakdown Responses to Increased Nutrient Delivery in Older Men, but Not Reduced Muscle Mass or Contractile Function. Diabetes 2015; 64:3160.
  90. Guillet C, Delcourt I, Rance M, et al. Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men. J Clin Endocrinol Metab 2009; 94:3044.
  91. Schmitz KH, Jensen MD, Kugler KC, et al. Strength training for obesity prevention in midlife women. Int J Obes Relat Metab Disord 2003; 27:326.
  92. Frimel TN, Sinacore DR, Villareal DT. Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci Sports Exerc 2008; 40:1213.
  93. Campbell WW, Haub MD, Wolfe RR, et al. Resistance training preserves fat-free mass without impacting changes in protein metabolism after weight loss in older women. Obesity (Silver Spring) 2009; 17:1332.
  94. Heymsfield SB, Gonzalez MC, Shen W, et al. Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes Rev 2014; 15:310.
  95. Hunter GR, Byrne NM, Sirikul B, et al. Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity (Silver Spring) 2008; 16:1045.
  96. Hunter GR, Bryan DR, Wetzstein CJ, et al. Resistance training and intra-abdominal adipose tissue in older men and women. Med Sci Sports Exerc 2002; 34:1023.
  97. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393.
  98. Ross R. Effects of diet- and exercise-induced weight loss on visceral adipose tissue in men and women. Sports Med 1997; 24:55.
  99. Kerksick C, Thomas A, Campbell B, et al. Effects of a popular exercise and weight loss program on weight loss, body composition, energy expenditure and health in obese women. Nutr Metab (Lond) 2009; 6:23.
  100. Mekary RA, Grøntved A, Despres JP, et al. Weight training, aerobic physical activities, and long-term waist circumference change in men. Obesity (Silver Spring) 2015; 23:461.
  101. Cauza E, Strehblow C, Metz-Schimmerl S, et al. Effects of progressive strength training on muscle mass in type 2 diabetes mellitus patients determined by computed tomography. Wien Med Wochenschr 2009; 159:141.
  102. Abe T, Kojima K, Kearns CF, et al. Whole body muscle hypertrophy from resistance training: distribution and total mass. Br J Sports Med 2003; 37:543.
  103. Wewege MA, Desai I, Honey C, et al. The Effect of Resistance Training in Healthy Adults on Body Fat Percentage, Fat Mass and Visceral Fat: A Systematic Review and Meta-Analysis. Sports Med 2022; 52:287.
  104. Beavers KM, Ambrosius WT, Rejeski WJ, et al. Effect of Exercise Type During Intentional Weight Loss on Body Composition in Older Adults with Obesity. Obesity (Silver Spring) 2017; 25:1823.
  105. Jensen J, Rustad PI, Kolnes AJ, Lai YC. The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise. Front Physiol 2011; 2:112.
  106. Conn VS, Koopman RJ, Ruppar TM, et al. Insulin Sensitivity Following Exercise Interventions: Systematic Review and Meta-Analysis of Outcomes Among Healthy Adults. J Prim Care Community Health 2014; 5:211.
  107. Brooks N, Layne JE, Gordon PL, et al. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci 2006; 4:19.
  108. Strasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010; 40:397.
  109. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43:1334.
  110. Colberg SR, Sigal RJ, Yardley JE, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016; 39:2065.
  111. https://health.gov/paguidelines/ (Accessed on November 30, 2017).
  112. Borghouts LB, Wagenmakers AJ, Goyens PL, Keizer HA. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise. Clin Sci (Lond) 2002; 103:559.
  113. Boon H, Blaak EE, Saris WH, et al. Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery. Diabetologia 2007; 50:103.
  114. Vianna JM, Lima JP, Saavedra FJ, Reis VM. Aerobic and Anaerobic Energy During Resistance Exercise at 80% 1RM. J Hum Kinet 2011; 29A:69.
  115. Holten MK, Zacho M, Gaster M, et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004; 53:294.
  116. Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48:1192.
  117. Braun B, Sharoff C, Chipkin SR, Beaudoin F. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol (1985) 2004; 97:991.
  118. Lee J, Kim D, Kim C. Resistance Training for Glycemic Control, Muscular Strength, and Lean Body Mass in Old Type 2 Diabetic Patients: A Meta-Analysis. Diabetes Ther 2017; 8:459.
  119. Wang Y, Simar D, Fiatarone Singh MA. Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: a systematic review. Diabetes Metab Res Rev 2009; 25:13.
  120. Burgomaster KA, Howarth KR, Phillips SM, et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol 2008; 586:151.
  121. Cuff DJ, Meneilly GS, Martin A, et al. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 2003; 26:2977.
  122. Ivy JL. Muscle glycogen synthesis before and after exercise. Sports Med 1991; 11:6.
  123. Campbell WW, Crim MC, Young VR, Evans WJ. Increased energy requirements and changes in body composition with resistance training in older adults. Am J Clin Nutr 1994; 60:167.
  124. Hunter GR, Wetzstein CJ, Fields DA, et al. Resistance training increases total energy expenditure and free-living physical activity in older adults. J Appl Physiol (1985) 2000; 89:977.
  125. Pratley R, Nicklas B, Rubin M, et al. Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men. J Appl Physiol (1985) 1994; 76:133.
  126. Ishiguro H, Kodama S, Horikawa C, et al. In Search of the Ideal Resistance Training Program to Improve Glycemic Control and its Indication for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Sports Med 2016; 46:67.
  127. Strasser B, Pesta D. Resistance training for diabetes prevention and therapy: experimental findings and molecular mechanisms. Biomed Res Int 2013; 2013:805217.
  128. Ashton RE, Tew GA, Aning JJ, et al. Effects of short-term, medium-term and long-term resistance exercise training on cardiometabolic health outcomes in adults: systematic review with meta-analysis. Br J Sports Med 2020; 54:341.
  129. Bweir S, Al-Jarrah M, Almalty AM, et al. Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes. Diabetol Metab Syndr 2009; 1:27.
  130. Grøntved A, Rimm EB, Willett WC, et al. A prospective study of weight training and risk of type 2 diabetes mellitus in men. Arch Intern Med 2012; 172:1306.
  131. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011; 96:2898.
  132. Marzolini S, Oh PI, Brooks D. Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. Eur J Prev Cardiol 2012; 19:81.
  133. Yamamoto S, Hotta K, Ota E, et al. Effects of resistance training on muscle strength, exercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: A meta-analysis. J Cardiol 2016; 68:125.
  134. Daub WD, Knapik GP, Black WR. Strength training early after myocardial infarction. J Cardiopulm Rehabil 1996; 16:100.
  135. Soufi FG, Saber MM, Ghiassie R, Alipour M. Role of 12-week resistance training in preserving the heart against ischemia-reperfusion-induced injury. Cardiol J 2011; 18:140.
  136. Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med 2014; 44:211.
  137. Kadoglou NP, Fotiadis G, Athanasiadou Z, et al. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes. Endocrine 2012; 42:561.
  138. MacDonald HV, Johnson BT, Huedo-Medina TB, et al. Dynamic Resistance Training as Stand-Alone Antihypertensive Lifestyle Therapy: A Meta-Analysis. J Am Heart Assoc 2016; 5.
  139. Zanchetti A. Looking forward with a grateful heart. J Hypertens 2010; 28:1.
  140. Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 2011; 58:950.
  141. de Sousa EC, Abrahin O, Ferreira ALL, et al. Resistance training alone reduces systolic and diastolic blood pressure in prehypertensive and hypertensive individuals: meta-analysis. Hypertens Res 2017; 40:927.
  142. Collier SR, Kanaley JA, Carhart R Jr, et al. Effect of 4 weeks of aerobic or resistance exercise training on arterial stiffness, blood flow and blood pressure in pre- and stage-1 hypertensives. J Hum Hypertens 2008; 22:678.
  143. Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010; 5:217.
  144. Carter CS, Onder G, Kritchevsky SB, Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol A Biol Sci Med Sci 2005; 60:1437.
  145. Di Bari M, van de Poll-Franse LV, Onder G, et al. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004; 52:961.
  146. Spira D, Walston J, Buchmann N, et al. Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II). Drugs Aging 2016; 33:829.
  147. Robinson MM, Bell C, Peelor FF 3rd, Miller BF. β-Adrenergic receptor blockade blunts postexercise skeletal muscle mitochondrial protein synthesis rates in humans. Am J Physiol Regul Integr Comp Physiol 2011; 301:R327.
  148. Lamont LS. Beta-blockers and their effects on protein metabolism and resting energy expenditure. J Cardiopulm Rehabil 1995; 15:183.
  149. Lee P, Kengne AP, Greenfield JR, et al. Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic? Int J Obes (Lond) 2011; 35:1395.
  150. Juhlin-Dannfelt A. Metabolic effects of beta-adrenoceptor blockade on skeletal muscle at rest and during exercise. Acta Med Scand Suppl 1982; 665:113.
  151. Wellstein A, Palm D, Belz GG, et al. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Eur Heart J 1987; 8 Suppl M:3.
  152. Josiak K, Jankowska EA, Piepoli MF, et al. Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones. J Cachexia Sarcopenia Muscle 2014; 5:287.
  153. Volaklis KA, Tokmakidis SP. Resistance exercise training in patients with heart failure. Sports Med 2005; 35:1085.
  154. Edelmann F, Gelbrich G, Düngen HD, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 2011; 58:1780.
  155. Jewiss D, Ostman C, Smart NA. The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis. Int J Cardiol 2016; 221:674.
  156. Giuliano C, Karahalios A, Neil C, et al. The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure - A meta-analysis. Int J Cardiol 2017; 227:413.
  157. McDermott MM, Criqui MH, Greenland P, et al. Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. J Vasc Surg 2004; 39:523.
  158. McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009; 301:165.
  159. Wang E, Helgerud J, Loe H, et al. Maximal strength training improves walking performance in peripheral arterial disease patients. Scand J Med Sci Sports 2010; 20:764.
  160. Lima A, Ritti-Dias R, Forjaz CL, et al. A session of resistance exercise increases vasodilation in intermittent claudication patients. Appl Physiol Nutr Metab 2015; 40:59.
  161. Mosti MP, Wang E, Wiggen ØN, et al. Concurrent strength and endurance training improves physical capacity in patients with peripheral arterial disease. Scand J Med Sci Sports 2011; 21:e308.
  162. Parmenter BJ, Mavros Y, Ritti Dias R, et al. Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis. Br J Sports Med 2020; 54:452.
  163. Maestroni L, Read P, Bishop C, et al. The Benefits of Strength Training on Musculoskeletal System Health: Practical Applications for Interdisciplinary Care. Sports Med 2020; 50:1431.
  164. Nilwik R, Snijders T, Leenders M, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 2013; 48:492.
  165. Verdijk LB, Snijders T, Drost M, et al. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr) 2014; 36:545.
  166. Frontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol (1985) 1988; 64:1038.
  167. Rejeski WJ, Ettinger WH Jr, Martin K, Morgan T. Treating disability in knee osteoarthritis with exercise therapy: a central role for self-efficacy and pain. Arthritis Care Res 1998; 11:94.
  168. Turner MN, Hernandez DO, Cade W, et al. The Role of Resistance Training Dosing on Pain and Physical Function in Individuals With Knee Osteoarthritis: A Systematic Review. Sports Health 2020; 12:200.
  169. Kristensen J, Franklyn-Miller A. Resistance training in musculoskeletal rehabilitation: a systematic review. Br J Sports Med 2012; 46:719.
  170. Vincent KR, Vincent HK. Resistance exercise for knee osteoarthritis. PM R 2012; 4:S45.
  171. Jan MH, Lin JJ, Liau JJ, et al. Investigation of clinical effects of high- and low-resistance training for patients with knee osteoarthritis: a randomized controlled trial. Phys Ther 2008; 88:427.
  172. Tanaka R, Ozawa J, Kito N, Moriyama H. Efficacy of strengthening or aerobic exercise on pain relief in people with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Clin Rehabil 2013; 27:1059.
  173. Suetta C, Magnusson SP, Rosted A, et al. Resistance training in the early postoperative phase reduces hospitalization and leads to muscle hypertrophy in elderly hip surgery patients--a controlled, randomized study. J Am Geriatr Soc 2004; 52:2016.
  174. Howe TE, Shea B, Dawson LJ, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2011; :CD000333.
  175. Rubin CT, Lanyon LE. Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 1985; 37:411.
  176. O'Connor JA, Lanyon LE, MacFie H. The influence of strain rate on adaptive bone remodelling. J Biomech 1982; 15:767.
  177. Maddalozzo GF, Widrick JJ, Cardinal BJ, et al. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Bone 2007; 40:1244.
  178. Watson SL, Weeks BK, Weis LJ, et al. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial. J Bone Miner Res 2018; 33:211.
  179. Jackson JK, Shepherd TR, Kell RT. The influence of periodized resistance training on recreationally active males with chronic nonspecific low back pain. J Strength Cond Res 2011; 25:242.
  180. Kell RT, Asmundson GJ. A comparison of two forms of periodized exercise rehabilitation programs in the management of chronic nonspecific low-back pain. J Strength Cond Res 2009; 23:513.
  181. Kell RT, Risi AD, Barden JM. The response of persons with chronic nonspecific low back pain to three different volumes of periodized musculoskeletal rehabilitation. J Strength Cond Res 2011; 25:1052.
  182. Carragee EJ, Alamin TF, Miller JL, Carragee JM. Discographic, MRI and psychosocial determinants of low back pain disability and remission: a prospective study in subjects with benign persistent back pain. Spine J 2005; 5:24.
  183. Ng SK, Cicuttini FM, Wang Y, et al. Negative beliefs about low back pain are associated with persistent high intensity low back pain. Psychol Health Med 2017; 22:790.
  184. Setchell J, Costa N, Ferreira M, et al. Individuals' explanations for their persistent or recurrent low back pain: a cross-sectional survey. BMC Musculoskelet Disord 2017; 18:466.
  185. Vincent HK, George SZ, Seay AN, et al. Resistance exercise, disability, and pain catastrophizing in obese adults with back pain. Med Sci Sports Exerc 2014; 46:1693.
  186. Mundt DJ, Kelsey JL, Golden AL, et al. An epidemiologic study of sports and weight lifting as possible risk factors for herniated lumbar and cervical discs. The Northeast Collaborative Group on Low Back Pain. Am J Sports Med 1993; 21:854.
  187. Layne JE, Nelson ME. The effects of progressive resistance training on bone density: a review. Med Sci Sports Exerc 1999; 31:25.
  188. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012; 3:225.
  189. Aamann L, Dam G, Rinnov AR, et al. Physical exercise for people with cirrhosis. Cochrane Database Syst Rev 2018; 12:CD012678.
  190. Tandon P, Ismond KP, Riess K, et al. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol 2018; 69:1164.
  191. Zelber-Sagi S, Buch A, Yeshua H, et al. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol 2014; 20:4382.
  192. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011; 60:1278.
  193. Shamsoddini A, Sobhani V, Ghamar Chehreh ME, et al. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. Hepat Mon 2015; 15:e31434.
  194. Hashida R, Kawaguchi T, Bekki M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol 2017; 66:142.
  195. Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985) 2013; 114:1222.
  196. Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis 2012; 7:523.
  197. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26:703.
  198. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62:115.
  199. Vonbank K, Strasser B, Mondrzyk J, et al. Strength training increases maximum working capacity in patients with COPD--randomized clinical trial comparing three training modalities. Respir Med 2012; 106:557.
  200. Troosters T, Probst VS, Crul T, et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181:1072.
  201. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008; 47:1124.
  202. Sokka T, Häkkinen A, Kautiainen H, et al. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum 2008; 59:42.
  203. Mikkelsen UR, Dideriksen K, Andersen MB, et al. Preserved skeletal muscle protein anabolic response to acute exercise and protein intake in well-treated rheumatoid arthritis patients. Arthritis Res Ther 2015; 17:271.
  204. Lemmey AB, Marcora SM, Chester K, et al. Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum 2009; 61:1726.
  205. Baillet A, Vaillant M, Guinot M, et al. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford) 2012; 51:519.
  206. Rall LC, Meydani SN, Kehayias JJ, et al. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum 1996; 39:415.
  207. Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr 2010; 91:1128S.
  208. Castaneda C, Gordon PL, Parker RC, et al. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 2004; 43:607.
  209. Castaneda C, Gordon PL, Uhlin KL, et al. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann Intern Med 2001; 135:965.
  210. Cheema BS, Chan D, Fahey P, Atlantis E. Effect of progressive resistance training on measures of skeletal muscle hypertrophy, muscular strength and health-related quality of life in patients with chronic kidney disease: a systematic review and meta-analysis. Sports Med 2014; 44:1125.
  211. Bessa B, de Oliveira Leal V, Moraes C, et al. Resistance training in hemodialysis patients: a review. Rehabil Nurs 2015; 40:111.
  212. Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain 2022; 23:134.
  213. Hafer-Macko CE, Ryan AS, Ivey FM, Macko RF. Skeletal muscle changes after hemiparetic stroke and potential beneficial effects of exercise intervention strategies. J Rehabil Res Dev 2008; 45:261.
  214. Ouellette MM, LeBrasseur NK, Bean JF, et al. High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors. Stroke 2004; 35:1404.
  215. Morris SL, Dodd KJ, Morris ME. Outcomes of progressive resistance strength training following stroke: a systematic review. Clin Rehabil 2004; 18:27.
  216. Wist S, Clivaz J, Sattelmayer M. Muscle strengthening for hemiparesis after stroke: A meta-analysis. Ann Phys Rehabil Med 2016; 59:114.
  217. Yang YR, Wang RY, Lin KH, et al. Task-oriented progressive resistance strength training improves muscle strength and functional performance in individuals with stroke. Clin Rehabil 2006; 20:860.
  218. Flansbjer UB, Lexell J, Brogårdh C. Long-term benefits of progressive resistance training in chronic stroke: a 4-year follow-up. J Rehabil Med 2012; 44:218.
  219. Kwakkel G, de Goede CJ, van Wegen EE. Impact of physical therapy for Parkinson's disease: a critical review of the literature. Parkinsonism Relat Disord 2007; 13 Suppl 3:S478.
  220. Dibble LE, Hale T, Marcus RL, et al. The safety and feasibility of high-force eccentric resistance exercise in persons with Parkinson's disease. Arch Phys Med Rehabil 2006; 87:1280.
  221. Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord 2013; 28:1230.
  222. Lima LO, Scianni A, Rodrigues-de-Paula F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review. J Physiother 2013; 59:7.
  223. Brienesse LA, Emerson MN. Effects of resistance training for people with Parkinson's disease: a systematic review. J Am Med Dir Assoc 2013; 14:236.
  224. Hass CJ, Buckley TA, Pitsikoulis C, Barthelemy EJ. Progressive resistance training improves gait initiation in individuals with Parkinson's disease. Gait Posture 2012; 35:669.
  225. Dibble LE, Hale TF, Marcus RL, et al. High intensity eccentric resistance training decreases bradykinesia and improves Quality Of Life in persons with Parkinson's disease: a preliminary study. Parkinsonism Relat Disord 2009; 15:752.
  226. Dibble LE, Hale TF, Marcus RL, et al. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson's disease. Mov Disord 2006; 21:1444.
  227. Gordon BR, MCDowell CP, Hallgren M et. Association of Efficacy of Resistance Exercise Training with Depressive Symptoms. JAMA Psychiatry 2018.
  228. Gordon BR, McDowell CP, Lyons M, Herring MP. The Effects of Resistance Exercise Training on Anxiety: A Meta-Analysis and Meta-Regression Analysis of Randomized Controlled Trials. Sports Med 2017; 47:2521.
  229. Pollock ML, Franklin BA, Balady GJ, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation 2000; 101:828.
  230. Hamill BP. Relative safety of weight lifting and weight training. J Strength Cond Res 1994; 8:53.
  231. Gehlsen GM, Ganion LR, Helfst R. Fibroblast responses to variation in soft tissue mobilization pressure. Med Sci Sports Exerc 1999; 31:531.
  232. Hollings M, Mavros Y, Freeston J, Fiatarone Singh M. The effect of progressive resistance training on aerobic fitness and strength in adults with coronary heart disease: A systematic review and meta-analysis of randomised controlled trials. Eur J Prev Cardiol 2017; 24:1242.
  233. Sharman JE, La Gerche A, Coombes JS. Exercise and cardiovascular risk in patients with hypertension. Am J Hypertens 2015; 28:147.
  234. Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36:533.
  235. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013; 128:873.
  236. Martín M, de la Hera J, Rozado J, et al. Response to Survivors of Aortic Dissection: Activity, Mental Health, and Sexual Function; and Exercise and Physical Activity for the Post-Aortic Dissection Patient: The Clinician's Conundrum. Clin Cardiol 2016; 39:243.
  237. Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 2001; 132:760.
  238. Liu CJ, Latham N. Adverse events reported in progressive resistance strength training trials in older adults: 2 sides of a coin. Arch Phys Med Rehabil 2010; 91:1471.
  239. Aasa U, Svartholm I, Andersson F, Berglund L. Injuries among weightlifters and powerlifters: a systematic review. Br J Sports Med 2017; 51:211.
  240. Keogh JW, Winwood PW. The Epidemiology of Injuries Across the Weight-Training Sports. Sports Med 2017; 47:479.
  241. Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA 2018; 320:2020.
  242. Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2017; 166:514.
  243. Vroomen PC, de Krom MC, Wilmink JT, et al. Lack of effectiveness of bed rest for sciatica. N Engl J Med 1999; 340:418.
  244. Hagen KB, Hilde G, Jamtvedt G, Winnem M. Bed rest for acute low-back pain and sciatica. Cochrane Database Syst Rev 2004; :CD001254.
  245. Tibana RA, Sousa NMF, Cunha GV, et al. Exertional Rhabdomyolysis after an Extreme Conditioning Competition: A Case Report. Sports (Basel) 2018; 6.
  246. Keltz E, Khan FY, Mann G. Rhabdomyolysis. The role of diagnostic and prognostic factors. Muscles Ligaments Tendons J 2013; 3:303.
  247. Rawson ES, Clarkson PM, Tarnopolsky MA. Perspectives on Exertional Rhabdomyolysis. Sports Med 2017; 47:33.
  248. Harmon KG, Drezner JA, Klossner D, Asif IM. Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator. Br J Sports Med 2012; 46:325.
  249. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care 2005; 9:158.
Topic 115880 Version 16.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟